Your browser doesn't support javascript.
loading
DFT Study of Regio- and Stereoselective 13DC Reaction between Diazopropane and Substituted Chalcone Derivatives: Molecular Docking of Novel Pyrazole Derivatives as Anti-Alzheimer's Agents.
Al-Hazmy, Sadeq M; Zouaghi, Mohamed Oussama; Amri, Nasser; Arfaoui, Youssef; Alhagri, Ibrahim A; Hamdi, Naceur.
Afiliación
  • Al-Hazmy SM; Chemistry Department, College of Science, Qassim University, Buraidah 51452, Saudi Arabia.
  • Zouaghi MO; Laboratory of Characterizations, Applications and Modeling of Materials (LR18ES08), Department of Chemistry, Faculty of Sciences, University of Tunis El Manar, Tunis 2092, Tunisia.
  • Amri N; Department of Chemistry, Faculty of Science, Jazan University, P.O. Box 2097, Jazan 45142, Saudi Arabia.
  • Arfaoui Y; Laboratory of Characterizations, Applications and Modeling of Materials (LR18ES08), Department of Chemistry, Faculty of Sciences, University of Tunis El Manar, Tunis 2092, Tunisia.
  • Alhagri IA; Chemistry Department, College of Science, Qassim University, Buraidah 51452, Saudi Arabia.
  • Hamdi N; Department of Chemistry, College of Science, Ibb University, Ibb P.O. Box 70270, Yemen.
Molecules ; 28(4)2023 Feb 16.
Article en En | MEDLINE | ID: mdl-36838888
In the present work, a combination of experimental and density functional theory (DFT) investigation of the (3+2) cycloaddition reactions of diazopropane with chalcone derivatives was reported. All calculations were performed using several DFT approaches (B3LYP, M06, M06-2X) and 6-311+G(d, p) basis set. Based on the NMR, MS analyses and IRC calculations, the pyrazole derivatives are the kinetic adducts over the oxadiazoles. The use of two equivalents of diazopropane leads to thermodynamical products. A molecular docking analysis was performed to investigate the efficiency of the obtained products against selected drug targets in anti-Alzheimer ligand-receptor interactions. We revealed that the ligands selected were bound mainly to the catalytic (CAS) and peripheral (PAS) anionic sites of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors, respectively. The selected ligands 1, 3, 4 and P14 may act as the best inhibitors against Alzheimer's disease (AD).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Chalcona / Chalconas / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Chalcona / Chalconas / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita